NCT06224582View on ClinicalTrials.gov

Yinxingmihuan Oral Solution in Treatment of Chest Pain After PCI

NACompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

December 30, 2020

Primary Completion Date

December 25, 2023

Study Completion Date

December 25, 2023

Conditions
Chronic Stable Angina
Interventions
DRUG

Yinxingmihuan oral solution

Yinxingmihuan oral solution is made of Ginkgo leaf extract and armillariella mellea powders.

DRUG

Placebo

The placebo oral solution is in the same appearance, color, smell and taste as the experimental Yinxingmihuan oral solution.

Trial Locations (1)

100037

Fuwai Hospital, National Center for Cardiovascular Diseases，Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors
lead

China National Center for Cardiovascular Diseases

OTHER_GOV

NCT06224582 - Yinxingmihuan Oral Solution in Treatment of Chest Pain After PCI | Biotech Hunter | Biotech Hunter